AAAAAA

   
Results: 1-7 |
Results: 7
Comparative abuse liability of intravenously administered remifentanil andfentanyl
Authors: Baylon, GJ Kaplan, HL Somer, G Busto, UE Sellers, EM
Citation: Gj. Baylon et al., Comparative abuse liability of intravenously administered remifentanil andfentanyl, J CL PSYCH, 20(6), 2000, pp. 597-606
A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam
Authors: Busto, UE Kaplan, HL Wright, CE Gomez-Mancilla, B Zawertailo, L Greenblatt, DJ Sellers, EM
Citation: Ue. Busto et al., A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam, J CL PSYCH, 20(6), 2000, pp. 628-635
Inhibition of cytochrome P450 2D6 modifies codeine abuse liability
Authors: Kathiramalainathan, K Kaplan, HL Romach, MK Busto, UE Li, NY Sawe, J Tyndale, RF Sellers, EM
Citation: K. Kathiramalainathan et al., Inhibition of cytochrome P450 2D6 modifies codeine abuse liability, J CL PSYCH, 20(4), 2000, pp. 435-444
Efficacy of dexfenfluramine in the treatment of alcohol dependence
Authors: Romach, MK Sellers, EM Kaplan, HL Somer, GR Gomez-Mancilla, B
Citation: Mk. Romach et al., Efficacy of dexfenfluramine in the treatment of alcohol dependence, ALC CLIN EX, 24(10), 2000, pp. 1534-1541
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking
Authors: Sellers, EM Kaplan, HL Tyndale, RF
Citation: Em. Sellers et al., Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking, CLIN PHARM, 68(1), 2000, pp. 35-43
Revised model simplified indenture
Authors: Amiel, PH Bancroft, AC Cohen, HT Crane, TC Davenport, KA Fisher, RE Gadsden, J Floyd, BB Hall, BH Heinzelman, KF Kaplan, HL McDaniel, MW Rahl, JA Reynolds, D Saggese, NP Simms, M Sharry, J Smith, F Wagner, SM
Citation: Ph. Amiel et al., Revised model simplified indenture, BUS LAWYER, 55(3), 2000, pp. 1115
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
Authors: Romach, MK Glue, P Kampman, K Kaplan, HL Somer, GR Poole, S Clarke, L Coffin, V Cornish, J O'Brien, CP Sellers, EM
Citation: Mk. Romach et al., Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166), ARCH G PSYC, 56(12), 1999, pp. 1101-1106
Risultati: 1-7 |